ConductScience.org, home

Paper12445288

GM-CSF-based cancer vaccines.

Dranoff G. Immunol Rev, 2002. Cited by 258 papers, by iCite.

Cite this record

ConductScience Library. GM-CSF-based cancer vaccines. Papers, record 12445288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12445288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GM-CSF-based cancer vaccines.
PubMed
Journal
Immunol Rev
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
258
iCite
Relative citation ratio, by iCite
4.43
iCite
Revised in PubMed
2021-01-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dranoff GGlenn

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cancer VaccinesMajor topic
Granulocyte-Macrophage Colony-Stimulating FactorMajor topic
NeoplasmsMajor topic
Adjuvants, Immunologic
Animals
Antigen Presentation
Antigen-Presenting Cells
Antigens, Neoplasm
Antigens, Surface
Clinical Trials, Phase I as Topic
Humans
Killer Cells, Natural
Melanoma
Mice
Neoplastic Stem Cells
T-Lymphocyte Subsets
Tumor Cells, Cultured
Vaccination

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA39542NCI NIH HHSUnited StatesP01CA039542PubMed and NIHNIH RePORTER
CA74886NCI NIH HHSUnited StatesR01CA074886PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by146

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.

PMIDTitleJournalYearIn PapersSource
42891082Immunocytokines in cancer: a safety perspective.Front Immunol2026https://conductscience.org/library/papers/42891082PubMed
42699170Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine.Mater Today Bio2026https://conductscience.org/library/papers/42699170PubMed
42506636Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions.Vaccines (Basel)2026https://conductscience.org/library/papers/42506636PubMed
42188765Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines.Vaccines (Basel)2026https://conductscience.org/library/papers/42188765PubMed
42170292Understanding the dual role of granulocyte-macrophage colony-stimulating factor in the lung cancer tumor microenvironment and its therapeutic implications.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42170292PubMed
41475842Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models.J Immunother Cancer2025https://conductscience.org/library/papers/41475842PubMed
41299103Natural products as therapeutic interventions for inflammation-mediated cancer.Discov Oncol2025https://conductscience.org/library/papers/41299103PubMed
40920775Targeting the Exon2 splice cis-element in PD-1 and its effects on lymphocyte function.PLoS One2025https://conductscience.org/library/papers/40920775PubMed
40887652
Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial.
Exp Hematol Oncol2025https://conductscience.org/library/papers/40887652PubMed
40878391Engineering Bacteria as Living Therapeutics in Cancer Therapy.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40878391PubMed
40437549Immunoprevention of non-viral cancers: challenges and strategies for early intervention.Cancer Cell Int2025https://conductscience.org/library/papers/40437549PubMed
40274339Anti-GM-CSF autoantibodies in myeloid leukemias.Best Pract Res Clin Haematol2025https://conductscience.org/library/papers/40274339PubMed
39335671Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.Biomedicines2024https://conductscience.org/library/papers/39335671PubMed
39041242A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors.Cancer Res Commun2024https://conductscience.org/library/papers/39041242PubMed
38933006Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.Fundam Res2023https://conductscience.org/library/papers/38933006PubMed
38656354A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases.Med Oncol2024https://conductscience.org/library/papers/38656354PubMed
38302823Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression and Long-Term Immune Memory.Adv Mater2024https://conductscience.org/library/papers/38302823PubMed
38043066Current status of vaccine immunotherapy for gastrointestinal cancers.Surg Today2024https://conductscience.org/library/papers/38043066PubMed
37539029Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins.iScience2023https://conductscience.org/library/papers/37539029PubMed
37262321Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.Cancer Immunol Res2023https://conductscience.org/library/papers/37262321PubMed

See all 146 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD1D912PubTator's text mininghttps://conductscience.org/library/genes/912

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12445288

GET https://conductscience.org/api/papers/v1/12445288/cited_by?page=2